In its approval letter, the FDA acknowledged that there is "a significant amount" of the Pfizer COVID-19 vaccine – produced under emergency use authorization (EUA) – still available for use while the pharmaceutical company has "insufficient stocks" of the newly licensed vaccine called Comirnaty.
The FDA ruled that Pfizer's COVID-19 vaccine under the EUA should remain unlicensed but can be used "interchangeably" with Comirnaty. It also pointed out that the licensed Comirnaty vaccine and Pfizer's existing COVID-19 vaccine under EUA are "legally distinct."
Under the circumstances, it was abundantly clear that the granting of full approval was a calculated move to encourage businesses and schools to impose vaccine mandates and enable Pfizer to unload inventories of its COVID-19 vaccine under EUA.
With the announcement that Pfizer's COVID-19 vaccine is now licensed, Americans will wrongly assume that vaccine mandates are lawful. (Related: Liberty Counsel: FDA approval doesn't mean Pfizer shots are 'safe.')
There is a huge real-world difference between products approved under EUA compared with those fully approved by the FDA.
EUA products are experimental under U.S. laws. Both the Nuremberg Code and federal regulations state that no one can force a human being to participate in the experiment. Under U.S. laws, it is unlawful to deny someone a job or an education because they refuse to be an experimental subject. Potential recipients have an absolute right to refuse experimental vaccines.
On the other hand, U.S. laws permit employers and schools to require students and workers to take licensed vaccines.
EUA-approved vaccines have an extraordinary liability shield under the 2005 Public Readiness and Preparedness Act. Vaccine manufacturers, distributors, providers and government planners are immune from liability.
The only way an injured party can sue is if he or she can prove willful misconduct and if the U.S. government has also brought an enforcement action against the party for willful misconduct. No such lawsuit has ever succeeded.
The Comirnaty vaccine is subject to the same product liability laws as other U.S. products. Licensed adult vaccines, including Comirnaty, do not enjoy any liability shield. People injured by the Comirnaty vaccine could potentially sue for damages. Jury awards could be astronomical, so Pfizer is unlikely to allow any American to take a Comirnaty vaccine until it can somehow arrange immunity for the product.
Members of the mainstream media were quick to report that vaccine mandates are now legal for military, healthcare workers, college students and employees in many industries following the full approval given to Pfizer's COVID-19 vaccine by the FDA.
The Pentagon promptly announced it will go ahead with its plan to force members of the military to get vaccinated against the virus following the announcement of the vaccine's full approval.
New York City announced on the same day that all public school teachers and other staffers will have to get vaccinated. One of the first to implement the requirement was the State University of New York (SUNY) system, which has nearly 400,000 students and more than 85,000 faculty members spread across its 64 campuses.
Several other prominent institutions are expected to impose vaccine mandates after consultation with their Boards of Trustees and state officials.
More likely than not, employees and students would get Pfizer's experimental COVID-19 vaccines under EUA – the same vaccine linked to cases of heart inflammation in teenagers and young adults and found to be ineffective at preventing symptomatic infections.
A study published by the Centers for Disease Control and Prevention (CDC) on July 30 found that 397 children between the ages of 12 and 17 were diagnosed with heart inflammation after receiving Pfizer's COVID-19 vaccine. In June, Israel's Ministry of Health also identified over 200 cases of heart inflammation in men between 16 and 30 years old, a vast majority of those happening at the younger end of that range.
Data published by Israel in July also found that Pfizer's COVID-19 vaccine was just 40.5 percent effective on average at preventing symptomatic infections.
An analysis, which was carried out as the delta variant became the dominant strain in Israel, appeared to show waning effectiveness of Pfizer’s COVID-19 vaccine. It was only 16 percent effective against symptomatic infections for those who had two doses back in January. For people that had received two doses by April, the efficacy rate against symptomatic infections stood at 79 percent.
President Joe Biden also endorsed the apparent scheme to trick Americans into getting experimental vaccines. (Related: Biden administration mulls COVID-19 vaccine mandate for federal workers amidst surge of "cases" following widespread vaccinations.)
"Let me say this loudly and clearly: If you're one of the millions of Americans who said that they will not get the shot until it has full and final approval of the FDA, it has now happened," Biden said. "The moment you've been waiting for is here. It's time for you to go get your vaccination. Get it today."
Biden also called for more private companies to implement vaccine mandates.
National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony Fauci went as far as saying that the time has come for a nationwide vaccine mandate.
"I know I respect people's freedom, but when you're talking about a public health crisis that we've been going through for well over a year and a half, the time has come. Enough is enough. We've just got to get people vaccinated," Fauci said.
"If we keep lingering without getting those people vaccinated that should be vaccinated, this thing could linger on, leading to the development of another variant which could complicate things."
Biden, Fauci and the mainstream were ignoring the fact that the FDA has not granted full approval to COVID-19 vaccines from Moderna and Johnson & Johnson. The federal agency has also not granted full approval to any COVID-19 vaccine for children between ages 12 and 15.
The vast majority, if not all, of COVID-19 vaccines available in the U.S., are unlicensed EUA products.
Follow Immunization.news for more news and information related to coronavirus vaccines.